Design, Synthesis, and Efficacy of Novel Trojan Horse Compounds Targeting Metabolic Vulnerabilities in Prostate Cancer
Laura Bogue Edgerton, Eva F. Hayball, Fiona O’Connell, M. P. Ward, Sharon A. O’Toole, Cara M. Martin, Stavros Selemidis, R. D. Brooks, Prerna Tewari, D. A. Brooks, John J. O’Leary
This study designs and tests Trojan Horse compounds targeting metabolic vulnerabilities in prostate cancer, showing promising cytotoxicity and selectivity in PCa cell lines.
bioRxiv · Aug 29, 2024 · PreprintCancer Biology